Cerity Partners
TWST icon

Cerity Partners’s Twist Bioscience TWST Stock Holding History

Cerity Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
13,396
+3,335
+33% +$217K ﹤0.01% 1793
2026
Q1 		$478K Buy
10,061
+1,196
+13% +$53.6K ﹤0.01% 2323
2025
Q4 		$281K Sell
8,865
-204
-2% -$6.37K ﹤0.01% 2448
2025
Q3 		$255K Buy
+9,069
New +$275K ﹤0.01% 2390
2025
Q1 		– Sell
-6,683
Closed -$309K – 2628
2024
Q4 		$309K Sell
6,683
-1,160
-15% -$52.4K ﹤0.01% 2014
2024
Q3 		$354K Buy
+7,843
New +$373K ﹤0.01% 1957

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Cerity Partners's TWST Position: Q2 2026 in Review

Cerity Partners increased its Twist Bioscience (TWST) stake by 33% in Q2 2026, buying an estimated $217K and bringing the position to 13,396 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Cerity Partners first reported a position in TWST in Q3 2024 and has held it in 6 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Cerity Partners held 13,396 shares of Twist Bioscience worth $1.38M as of Q2 2026.
  • Cerity Partners bought 3,335 Twist Bioscience shares in Q2 2026, an estimated $217K.
  • Twist Bioscience made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1793 holding.
  • Cerity Partners first reported a position in Twist Bioscience in Q3 2024 and has held it in 6 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.